Trial intelligence / Profile preview

Randomized controlled study of pramipexole for Parkinson's disease

ChiCTR-TRC-07000027Phase 4Completed

Sponsor
First Affiliated Hospital of Xinjiang Medical University
Start
Nov 2007
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Pramipexole or Ropinirole in Parkinson's disease (PD) (3 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoint: Daily life and movement motor function score. Started Nov 2007; status: completed.

02

Drugs

Pramipexole or Ropinirole
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on ChiCTR-TRC-07000027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-07000027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call